← Back to headlines



Sandoz Expands Biosimilars Business with Chinese Biotech Deal
Sandoz has announced an expansion of its biosimilars business through a new deal with a Chinese biotech company. This strategic partnership aims to strengthen Sandoz's presence in the global biosimilars market.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories

Global Outage Disrupts Microsoft Outlook and Exchange Online Services
42m ago

FTC and 22 States Sue Amazon Over Alleged Advertising Price Manipulation
50m ago
Instagram cracks down on unlabeled AI influencers amid Nepal flood disinformation
3h ago

EU Designates ChatGPT, Reddit, and Roblox Under Stricter Digital Rules
3h ago